{
    "info": {
        "nct_id": "NCT05695339",
        "official_title": "Phase I Open Label Clinical Trial Using Resiniferatoxin, A Non-Opioid Medication, For the Management of Refractory Morton's Neuroma Pain",
        "inclusion_criteria": "* INCLUSION CRITERIA:\n\nBoth male and female participants are eligible for study evaluation. There are no exclusions for any racial/ethnic groups. Efforts will be made to extend accrual to a representative population. In order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n* Provision of signed and dated informed consent form.\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n* Must be able to read, write, understand, and complete English-language study-related forms and adequately communicate in English.\n* Stated willingness to comply with all study procedures and availability for the duration of the study.\n* Male or female, aged 18 and older.\n* In good general health as evidenced by medical history.\n* Diagnosed with one painful Morton s neuroma in the index foot\n* Has not attained satisfactory pain relief with conservative, oral analgesic and at least one kind of injection treatment for Morton s neuroma.\n* Exhibits moderate to severe foot pain due to the Morton s neuroma (average worst pain >= 5 on the 0-10 numeric pain rating scale NRS) as assessed verbally at >= 3 individual days during prescreening.\n* For females of reproductive potential who are sexually active: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional one (1) month after administration of RTX.\n\nIf a female, be sterile (surgically or biologically) * or at least one year postmenopausal**, or have a monogamous partner who is surgically sterile, or have a same sex partner, or if in a heterosexual relationship, must agree to do the following for at least one month after receiving investigational product (IP):\n\n* Practice abstinence, or\n* Use at least one of the following medically acceptable methods of birth control:\n\n  * Hormonal methods such as oral, implantable, injectable, vaginal ring, or transdermal contraceptives (must have started a minimum of 1 full cycle, based on the subject s usual menstrual cycle period, before IP dose\n  * Intrauterine device\n  * Double-barrier method (condoms, sponge, or diaphragm with spermicidal jellies or cream).\n\n    * Defined as having had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion at least 6 weeks prior to screening; or having a congenital or acquired condition that prevents childbearing\n\n      * Defined as at least 12 months with no menses without an alternative medical cause) [can be confirmed with follicle stimulating hormone level (FSH) in the post-menopausal range (FSH levels >=40 milli international units/mL (mIU/mL) at Screening) if the subject is not on hormonal replacement therapy]\n* For males of reproductive potential who are sexually active: use of condoms or other methods to ensure effective contraception with partner for one (1) month after administration of (RTX).\n\nIf a male of reproductive potential, unless he has a same sex partner or a partner who is sterile or at least one year post-menopausal, must agree to do the following for at least one month after receiving IP\n\n* practice abstinence from heterosexual activity or\n* use (or have their partner use) acceptable contraception (see criterion above) during heterosexual activity\n\nMale study participants should not donate sperm for 3 months after RTX injection.\n\nEXCLUSION CRITERIA:\n\nAn individual who meets any of the following criteria will be excluded from participation in this study:\n\n* Pregnancy or lactation.\n* Has a known allergy or hypersensitivity to chili peppers or capsaicin.\n* Has a known allergy to local anesthetics.\n* Has active or history of rheumatoid arthritis or peripheral neuropathy.\n* Has a prolonged baseline QTc interval exceeding 480 milliseconds.\n* Current presentation of other currently painful pathology of the same foot affected by Morton s neuroma, including, but not limited to, hallux valgus, plantar fasciitis, hammer toes, metatarsalgia, bursitis.\n* History of injection and/or ablation treatments treatment in the affected foot up to one month previous to study participation.\n* History of nerve excision due to Morton s neuroma in the location to be treated with RTX.\n* Active cutaneous disease, inflammation or infection at the anticipated site of study drug injection.\n* Has diabetes mellitus or peripheral vascular disease whether poorly managed or stable.\n* Has more than one Morton s neuroma in the index foot scheduled to receive the treatment intervention.\n* Other clinically significant condition that might interfere with study participation or greatly increases safety risk to the subject, as judged by the study investigator.\n* Concurrent treatment with another investigational drug or other intervention within last month.\n* Cognitive or language difficulties that would impair comprehension or completion of the assessment instruments.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Has more than one Morton s neuroma in the index foot scheduled to receive the treatment intervention.",
            "criterions": [
                {
                    "exact_snippets": "Has more than one Morton s neuroma in the index foot",
                    "criterion": "Morton's neuroma in the index foot",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "neuroma"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "index foot scheduled to receive the treatment intervention",
                    "criterion": "index foot",
                    "requirements": [
                        {
                            "requirement_type": "scheduled for treatment intervention",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a prolonged baseline QTc interval exceeding 480 milliseconds.",
            "criterions": [
                {
                    "exact_snippets": "prolonged baseline QTc interval exceeding 480 milliseconds",
                    "criterion": "QTc interval",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 480,
                                "unit": "milliseconds"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of nerve excision due to Morton s neuroma in the location to be treated with RTX.",
            "criterions": [
                {
                    "exact_snippets": "History of nerve excision due to Morton s neuroma in the location to be treated with RTX.",
                    "criterion": "nerve excision due to Morton's neuroma in the location to be treated with RTX",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a known allergy to local anesthetics.",
            "criterions": [
                {
                    "exact_snippets": "Has a known allergy to local anesthetics",
                    "criterion": "allergy to local anesthetics",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "known",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Provision of signed and dated informed consent form.",
            "criterions": [
                {
                    "exact_snippets": "Provision of signed and dated informed consent form",
                    "criterion": "informed consent form",
                    "requirements": [
                        {
                            "requirement_type": "provision",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "dated",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability of subject to understand and the willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Ability of subject to understand",
                    "criterion": "subject's ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* use (or have their partner use) acceptable contraception (see criterion above) during heterosexual activity",
            "criterions": [
                {
                    "exact_snippets": "use (or have their partner use) acceptable contraception ... during heterosexual activity",
                    "criterion": "contraception use during heterosexual activity",
                    "requirements": [
                        {
                            "requirement_type": "use of acceptable contraception",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cognitive or language difficulties that would impair comprehension or completion of the assessment instruments.",
            "criterions": [
                {
                    "exact_snippets": "Cognitive or language difficulties that would impair comprehension or completion of the assessment instruments.",
                    "criterion": "cognitive difficulties",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Cognitive or language difficulties that would impair comprehension or completion of the assessment instruments.",
                    "criterion": "language difficulties",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stated willingness to comply with all study procedures and availability for the duration of the study.",
            "criterions": [
                {
                    "exact_snippets": "Stated willingness to comply with all study procedures",
                    "criterion": "willingness to comply with study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "availability for the duration of the study",
                    "criterion": "availability for the duration of the study",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must be able to read, write, understand, and complete English-language study-related forms and adequately communicate in English.",
            "criterions": [
                {
                    "exact_snippets": "Must be able to read ... English-language study-related forms",
                    "criterion": "English reading ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Must be able to ... write ... English-language study-related forms",
                    "criterion": "English writing ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Must be able to ... understand ... English-language study-related forms",
                    "criterion": "English comprehension ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Must be able to ... complete English-language study-related forms",
                    "criterion": "English form completion ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequately communicate in English",
                    "criterion": "English communication ability",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent treatment with another investigational drug or other intervention within last month.",
            "criterions": [
                {
                    "exact_snippets": "Concurrent treatment with another investigational drug",
                    "criterion": "concurrent treatment with investigational drug",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Concurrent treatment with ... other intervention within last month",
                    "criterion": "concurrent treatment with other intervention",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Male study participants should not donate sperm for 3 months after RTX injection.",
            "criterions": [
                {
                    "exact_snippets": "Male study participants",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": "male"
                        }
                    ]
                },
                {
                    "exact_snippets": "should not donate sperm for 3 months after RTX injection",
                    "criterion": "sperm donation",
                    "requirements": [
                        {
                            "requirement_type": "prohibition_duration",
                            "expected_value": {
                                "operator": "=",
                                "value": 3,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "timing_reference",
                            "expected_value": "after RTX injection"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Intrauterine device",
            "criterions": [
                {
                    "exact_snippets": "Intrauterine device",
                    "criterion": "intrauterine device",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has a known allergy or hypersensitivity to chili peppers or capsaicin.",
            "criterions": [
                {
                    "exact_snippets": "Has a known allergy or hypersensitivity to chili peppers",
                    "criterion": "allergy to chili peppers",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Has a known ... hypersensitivity to chili peppers",
                    "criterion": "hypersensitivity to chili peppers",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Has a known allergy or hypersensitivity to ... capsaicin",
                    "criterion": "allergy or hypersensitivity to capsaicin",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has not attained satisfactory pain relief with conservative, oral analgesic and at least one kind of injection treatment for Morton s neuroma.",
            "criterions": [
                {
                    "exact_snippets": "Has not attained satisfactory pain relief",
                    "criterion": "pain relief",
                    "requirements": [
                        {
                            "requirement_type": "satisfaction",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "with conservative, oral analgesic and at least one kind of injection treatment for Morton s neuroma",
                    "criterion": "prior treatments for Morton's neuroma",
                    "requirements": [
                        {
                            "requirement_type": "treatment types tried",
                            "expected_value": [
                                "conservative",
                                "oral analgesic",
                                "at least one kind of injection"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Exhibits moderate to severe foot pain due to the Morton s neuroma (average worst pain >= 5 on the 0-10 numeric pain rating scale NRS) as assessed verbally at >= 3 individual days during prescreening.",
            "criterions": [
                {
                    "exact_snippets": "Exhibits moderate to severe foot pain due to the Morton s neuroma",
                    "criterion": "foot pain due to Morton's neuroma",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": [
                                "moderate",
                                "severe"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "average worst pain >= 5 on the 0-10 numeric pain rating scale NRS",
                    "criterion": "average worst pain (NRS)",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5,
                                "unit": "NRS (0-10)"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "as assessed verbally at >= 3 individual days during prescreening",
                    "criterion": "number of days with verbal pain assessment during prescreening",
                    "requirements": [
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For males of reproductive potential who are sexually active: use of condoms or other methods to ensure effective contraception with partner for one (1) month after administration of (RTX).",
            "criterions": [
                {
                    "exact_snippets": "males of reproductive potential",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "male"
                        },
                        {
                            "requirement_type": "reproductive potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sexually active",
                    "criterion": "sexual activity",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "sexually active"
                        }
                    ]
                },
                {
                    "exact_snippets": "use of condoms or other methods to ensure effective contraception with partner for one (1) month after administration of (RTX)",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "contraception method",
                            "expected_value": [
                                "condoms",
                                "other methods to ensure effective contraception"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "month"
                            }
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "after administration of (RTX)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Use at least one of the following medically acceptable methods of birth control:",
            "criterions": [
                {
                    "exact_snippets": "Use at least one of the following medically acceptable methods of birth control",
                    "criterion": "birth control method",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": "medically acceptable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has diabetes mellitus or peripheral vascular disease whether poorly managed or stable.",
            "criterions": [
                {
                    "exact_snippets": "Has diabetes mellitus",
                    "criterion": "diabetes mellitus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "peripheral vascular disease",
                    "criterion": "peripheral vascular disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "If a female, be sterile (surgically or biologically) * or at least one year postmenopausal**, or have a monogamous partner who is surgically sterile, or have a same sex partner, or if in a heterosexual relationship, must agree to do the following for at least one month after receiving investigational product (IP):",
            "criterions": [
                {
                    "exact_snippets": "If a female, be sterile (surgically or biologically)",
                    "criterion": "female sterility",
                    "requirements": [
                        {
                            "requirement_type": "sterility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least one year postmenopausal",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "postmenopausal_duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "have a monogamous partner who is surgically sterile",
                    "criterion": "partner sterility (monogamous)",
                    "requirements": [
                        {
                            "requirement_type": "partner_sterility",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "relationship_type",
                            "expected_value": "monogamous"
                        }
                    ]
                },
                {
                    "exact_snippets": "have a same sex partner",
                    "criterion": "partner sex",
                    "requirements": [
                        {
                            "requirement_type": "partner_sex",
                            "expected_value": "same sex"
                        }
                    ]
                },
                {
                    "exact_snippets": "if in a heterosexual relationship, must agree to do the following for at least one month after receiving investigational product (IP)",
                    "criterion": "contraceptive agreement in heterosexual relationship",
                    "requirements": [
                        {
                            "requirement_type": "relationship_type",
                            "expected_value": "heterosexual"
                        },
                        {
                            "requirement_type": "contraceptive_agreement_duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Defined as having had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion at least 6 weeks prior to screening; or having a congenital or acquired condition that prevents childbearing",
            "criterions": [
                {
                    "exact_snippets": "having had a hysterectomy",
                    "criterion": "hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bilateral oophorectomy",
                    "criterion": "bilateral oophorectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bilateral salpingectomy",
                    "criterion": "bilateral salpingectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bilateral tubal ligation/occlusion",
                    "criterion": "bilateral tubal ligation or occlusion",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 6 weeks prior to screening",
                    "criterion": "time since sterilization procedure",
                    "requirements": [
                        {
                            "requirement_type": "minimum time since procedure",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "weeks"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "congenital or acquired condition that prevents childbearing",
                    "criterion": "condition preventing childbearing",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* In good general health as evidenced by medical history.",
            "criterions": [
                {
                    "exact_snippets": "In good general health as evidenced by medical history.",
                    "criterion": "general health",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "good"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnancy or lactation.",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "Both male and female participants are eligible for study evaluation. There are no exclusions for any racial/ethnic groups. Efforts will be made to extend accrual to a representative population. In order to be eligible to participate in this study, an individual must meet all of the following criteria:",
            "criterions": [
                {
                    "exact_snippets": "Both male and female participants are eligible for study evaluation.",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "There are no exclusions for any racial/ethnic groups.",
                    "criterion": "race/ethnicity",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current presentation of other currently painful pathology of the same foot affected by Morton s neuroma, including, but not limited to, hallux valgus, plantar fasciitis, hammer toes, metatarsalgia, bursitis.",
            "criterions": [
                {
                    "exact_snippets": "Current presentation of other currently painful pathology of the same foot affected by Morton s neuroma",
                    "criterion": "painful pathology of the same foot affected by Morton's neuroma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hallux valgus",
                    "criterion": "hallux valgus",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "plantar fasciitis",
                    "criterion": "plantar fasciitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hammer toes",
                    "criterion": "hammer toes",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "metatarsalgia",
                    "criterion": "metatarsalgia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bursitis",
                    "criterion": "bursitis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Double-barrier method (condoms, sponge, or diaphragm with spermicidal jellies or cream).",
            "criterions": [
                {
                    "exact_snippets": "Double-barrier method (condoms, sponge, or diaphragm with spermicidal jellies or cream)",
                    "criterion": "contraception method",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "double-barrier method"
                            ]
                        },
                        {
                            "requirement_type": "acceptable_methods",
                            "expected_value": [
                                "condoms",
                                "sponge",
                                "diaphragm with spermicidal jellies or cream"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* practice abstinence from heterosexual activity or",
            "criterions": [
                {
                    "exact_snippets": "practice abstinence from heterosexual activity",
                    "criterion": "heterosexual activity",
                    "requirements": [
                        {
                            "requirement_type": "abstinence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active cutaneous disease, inflammation or infection at the anticipated site of study drug injection.",
            "criterions": [
                {
                    "exact_snippets": "Active cutaneous disease ... at the anticipated site of study drug injection",
                    "criterion": "cutaneous disease at injection site",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "inflammation ... at the anticipated site of study drug injection",
                    "criterion": "inflammation at injection site",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "infection at the anticipated site of study drug injection",
                    "criterion": "infection at injection site",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hormonal methods such as oral, implantable, injectable, vaginal ring, or transdermal contraceptives (must have started a minimum of 1 full cycle, based on the subject s usual menstrual cycle period, before IP dose",
            "criterions": [
                {
                    "exact_snippets": "Hormonal methods such as oral, implantable, injectable, vaginal ring, or transdermal contraceptives",
                    "criterion": "contraceptive method",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "oral",
                                "implantable",
                                "injectable",
                                "vaginal ring",
                                "transdermal"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "must have started a minimum of 1 full cycle, based on the subject s usual menstrual cycle period, before IP dose",
                    "criterion": "contraceptive use duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "full menstrual cycle"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male or female, aged 18 and older.",
            "criterions": [
                {
                    "exact_snippets": "Male or female",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "aged 18 and older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Has active or history of rheumatoid arthritis or peripheral neuropathy.",
            "criterions": [
                {
                    "exact_snippets": "Has active or history of rheumatoid arthritis",
                    "criterion": "rheumatoid arthritis",
                    "requirements": [
                        {
                            "requirement_type": "activity or history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Has active or history of ... peripheral neuropathy",
                    "criterion": "peripheral neuropathy",
                    "requirements": [
                        {
                            "requirement_type": "activity or history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Practice abstinence, or",
            "criterions": [
                {
                    "exact_snippets": "Practice abstinence",
                    "criterion": "sexual activity",
                    "requirements": [
                        {
                            "requirement_type": "abstinence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosed with one painful Morton s neuroma in the index foot",
            "criterions": [
                {
                    "exact_snippets": "Diagnosed with one painful Morton s neuroma in the index foot",
                    "criterion": "Morton's neuroma in the index foot",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        },
                        {
                            "requirement_type": "painful",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "If a male of reproductive potential, unless he has a same sex partner or a partner who is sterile or at least one year post-menopausal, must agree to do the following for at least one month after receiving IP",
            "criterions": [
                {
                    "exact_snippets": "male of reproductive potential",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "male"
                        },
                        {
                            "requirement_type": "reproductive potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unless he has a same sex partner",
                    "criterion": "partner sex",
                    "requirements": [
                        {
                            "requirement_type": "partner sex",
                            "expected_value": "same sex"
                        }
                    ]
                },
                {
                    "exact_snippets": "unless he has ... a partner who is sterile",
                    "criterion": "partner fertility status",
                    "requirements": [
                        {
                            "requirement_type": "partner fertility status",
                            "expected_value": "sterile"
                        }
                    ]
                },
                {
                    "exact_snippets": "unless he has ... a partner who is ... at least one year post-menopausal",
                    "criterion": "partner menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "menopausal status",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year post-menopausal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of injection and/or ablation treatments treatment in the affected foot up to one month previous to study participation.",
            "criterions": [
                {
                    "exact_snippets": "History of injection and/or ablation treatments treatment in the affected foot up to one month previous to study participation.",
                    "criterion": "injection or ablation treatments in affected foot",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "month prior to study participation"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Other clinically significant condition that might interfere with study participation or greatly increases safety risk to the subject, as judged by the study investigator.",
            "criterions": [
                {
                    "exact_snippets": "Other clinically significant condition that might interfere with study participation",
                    "criterion": "clinically significant condition",
                    "requirements": [
                        {
                            "requirement_type": "potential to interfere with study participation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Other clinically significant condition that ... greatly increases safety risk to the subject",
                    "criterion": "clinically significant condition",
                    "requirements": [
                        {
                            "requirement_type": "potential to greatly increase safety risk to the subject",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "as judged by the study investigator",
                    "criterion": "study investigator judgment",
                    "requirements": [
                        {
                            "requirement_type": "judgment",
                            "expected_value": "as judged by the study investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Defined as at least 12 months with no menses without an alternative medical cause) [can be confirmed with follicle stimulating hormone level (FSH) in the post-menopausal range (FSH levels >=40 milli international units/mL (mIU/mL) at Screening) if the subject is not on hormonal replacement therapy]",
            "criterions": [
                {
                    "exact_snippets": "at least 12 months with no menses without an alternative medical cause",
                    "criterion": "menstrual status",
                    "requirements": [
                        {
                            "requirement_type": "absence of menses duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "alternative medical cause",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "follicle stimulating hormone level (FSH) in the post-menopausal range (FSH levels >=40 milli international units/mL (mIU/mL) at Screening) if the subject is not on hormonal replacement therapy",
                    "criterion": "follicle stimulating hormone (FSH) level",
                    "requirements": [
                        {
                            "requirement_type": "FSH level",
                            "expected_value": {
                                "operator": ">=",
                                "value": 40,
                                "unit": "mIU/mL"
                            }
                        },
                        {
                            "requirement_type": "hormonal replacement therapy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For females of reproductive potential who are sexually active: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional one (1) month after administration of RTX.",
            "criterions": [
                {
                    "exact_snippets": "females of reproductive potential",
                    "criterion": "reproductive potential (female)",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sexually active",
                    "criterion": "sexual activity",
                    "requirements": [
                        {
                            "requirement_type": "sexual activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "use of highly effective contraception for at least 1 month prior to screening",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "contraception type",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration prior to screening",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "agreement to use such a method during study participation and for an additional one (1) month after administration of RTX",
                    "criterion": "contraception use during and after study",
                    "requirements": [
                        {
                            "requirement_type": "contraception type",
                            "expected_value": "highly effective"
                        },
                        {
                            "requirement_type": "duration during study",
                            "expected_value": "entire study participation"
                        },
                        {
                            "requirement_type": "duration after RTX",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* INCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "EXCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "An individual who meets any of the following criteria will be excluded from participation in this study:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}